# The Effects of Enoximone in Acute Exacerbation COPD

> **NCT04420455** · PHASE4 · TERMINATED · sponsor: **Rijnstate Hospital** · enrollment: 3 (actual)

## Conditions studied

- COPD Exacerbation
- Enoximone
- Phosphodiesterase Inhibitor

## Interventions

- **DRUG:** Enoximone

## Key facts

- **NCT ID:** NCT04420455
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-12
- **Primary completion:** 2021-12-21
- **Final completion:** 2021-12-21
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** A limited number of inclusions due to the Covid-pandemic
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04420455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04420455, "The Effects of Enoximone in Acute Exacerbation COPD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04420455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*